yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
2
Q37130018-2C5C0E59-07DD-437F-8EBF-6F9DD0513BB8
Q37130018-2C5C0E59-07DD-437F-8EBF-6F9DD0513BB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37130018-2C5C0E59-07DD-437F-8EBF-6F9DD0513BB8
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients.
P2860
Q37130018-2C5C0E59-07DD-437F-8EBF-6F9DD0513BB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37130018-2C5C0E59-07DD-437F-8EBF-6F9DD0513BB8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82d2951440dc7518820e6972a3444c4daf13d833
P2860
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab'